BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 31911495)

  • 1. CARD9 Is Required for Classical Macrophage Activation and the Induction of Protective Immunity against Pulmonary Cryptococcosis.
    Campuzano A; Castro-Lopez N; Martinez AJ; Olszewski MA; Ganguly A; Leopold Wager C; Hung CY; Wormley FL
    mBio; 2020 Jan; 11(1):. PubMed ID: 31911495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis.
    Wozniak KL; Ravi S; Macias S; Young ML; Olszewski MA; Steele C; Wormley FL
    PLoS One; 2009 Sep; 4(9):e6854. PubMed ID: 19727388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defect of CARD9 leads to impaired accumulation of gamma interferon-producing memory phenotype T cells in lungs and increased susceptibility to pulmonary infection with Cryptococcus neoformans.
    Yamamoto H; Nakamura Y; Sato K; Takahashi Y; Nomura T; Miyasaka T; Ishii K; Hara H; Yamamoto N; Kanno E; Iwakura Y; Kawakami K
    Infect Immun; 2014 Apr; 82(4):1606-15. PubMed ID: 24470469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation.
    Hardison SE; Herrera G; Young ML; Hole CR; Wozniak KL; Wormley FL
    J Immunol; 2012 Oct; 189(8):4060-8. PubMed ID: 22984078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection.
    Hardison SE; Wozniak KL; Kolls JK; Wormley FL
    Infect Immun; 2010 Dec; 78(12):5341-51. PubMed ID: 20921149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice.
    Leopold Wager CM; Hole CR; Wozniak KL; Olszewski MA; Wormley FL
    J Immunol; 2014 Oct; 193(8):4060-71. PubMed ID: 25200956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans.
    Leopold Wager CM; Hole CR; Wozniak KL; Olszewski MA; Mueller M; Wormley FL
    Infect Immun; 2015 Dec; 83(12):4513-27. PubMed ID: 26351277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptococcal heat shock protein 70 homolog Ssa1 contributes to pulmonary expansion of Cryptococcus neoformans during the afferent phase of the immune response by promoting macrophage M2 polarization.
    Eastman AJ; He X; Qiu Y; Davis MJ; Vedula P; Lyons DM; Park YD; Hardison SE; Malachowski AN; Osterholzer JJ; Wormley FL; Williamson PR; Olszewski MA
    J Immunol; 2015 Jun; 194(12):5999-6010. PubMed ID: 25972480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of host immune responses to pulmonary cryptococcosis using a temperature-sensitive C. neoformans calcineurin A mutant strain.
    Wormley FL; Cox GM; Perfect JR
    Microb Pathog; 2005; 38(2-3):113-23. PubMed ID: 15748813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DAP12 Inhibits Pulmonary Immune Responses to Cryptococcus neoformans.
    Heung LJ; Hohl TM
    Infect Immun; 2016 Jun; 84(6):1879-86. PubMed ID: 27068093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection.
    Hardison SE; Ravi S; Wozniak KL; Young ML; Olszewski MA; Wormley FL
    Am J Pathol; 2010 Feb; 176(2):774-85. PubMed ID: 20056835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptococcus neoformans Evades Pulmonary Immunity by Modulating Xylose Precursor Transport.
    Li LX; Hole CR; Rangel-Moreno J; Khader SA; Doering TL
    Infect Immun; 2020 Jul; 88(8):. PubMed ID: 32423915
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of Dectin-2 in the Phagocytosis of Cryptococcus neoformans by Dendritic Cells.
    Kitai Y; Sato K; Tanno D; Yuan X; Umeki A; Kasamatsu J; Kanno E; Tanno H; Hara H; Yamasaki S; Saijo S; Iwakura Y; Ishii K; Kawakami K
    Infect Immun; 2021 Sep; 89(10):e0033021. PubMed ID: 34251289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group 2 Innate Lymphoid Cells (ILC2) Suppress Beneficial Type 1 Immune Responses During Pulmonary Cryptococcosis.
    Kindermann M; Knipfer L; Obermeyer S; Müller U; Alber G; Bogdan C; Schleicher U; Neurath MF; Wirtz S
    Front Immunol; 2020; 11():209. PubMed ID: 32117319
    [No Abstract]   [Full Text] [Related]  

  • 15. Dectin-3 Recognizes Glucuronoxylomannan of
    Huang HR; Li F; Han H; Xu X; Li N; Wang S; Xu JF; Jia XM
    Front Immunol; 2018; 9():1781. PubMed ID: 30131805
    [No Abstract]   [Full Text] [Related]  

  • 16. Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice.
    Wozniak KL; Young ML; Wormley FL
    Clin Vaccine Immunol; 2011 May; 18(5):717-23. PubMed ID: 21450975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation via Toll-like receptor 9 reduces Cryptococcus neoformans-induced pulmonary inflammation in an IL-12-dependent manner.
    Edwards L; Williams AE; Krieg AM; Rae AJ; Snelgrove RJ; Hussell T
    Eur J Immunol; 2005 Jan; 35(1):273-81. PubMed ID: 15597328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of Protective Immunity to Cryptococcal Infection in Mice by a Heat-Killed, Chitosan-Deficient Strain of Cryptococcus neoformans.
    Upadhya R; Lam WC; Maybruck B; Specht CA; Levitz SM; Lodge JK
    mBio; 2016 May; 7(3):. PubMed ID: 27165801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptococcus neoformans Chitin Synthase 3 Plays a Critical Role in Dampening Host Inflammatory Responses.
    Hole CR; Lam WC; Upadhya R; Lodge JK
    mBio; 2020 Feb; 11(1):. PubMed ID: 32071275
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection.
    Olszewski MA; Huffnagle GB; McDonald RA; Lindell DM; Moore BB; Cook DN; Toews GB
    J Immunol; 2000 Dec; 165(11):6429-36. PubMed ID: 11086082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.